Cite
HARVARD Citation
Verlingue, L. et al. (2018). Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door. European journal of cancer. pp. 1-10. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Verlingue, L. et al. (2018). Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door. European journal of cancer. pp. 1-10. [Online].